Immutep secures second IND approval for anti-cancer drug
The IND approval will enable the company to ship eftilagimod across US state borders to clinical investigators participating…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
09 Mar 20
The IND approval will enable the company to ship eftilagimod across US state borders to clinical investigators participating…
27 Feb 20
Gilead has started the clinical studies, following the US Food and Drug Administration (FDA) acceptance of its investigational…
In clinical trials, the new IV treatment was shown to reduce symptoms of migraines — including headaches, nausea…
Pheno Therapeutics will investigate new multiple sclerosis treatments using technology and expertise from the University of Edinburgh
The study in Finland builds on work of the GDNF drug, which has shown promise in restoring damaged…
Solid tumours, and types of breast and lung cancer look set to be the most common indications for…
11 Feb 20
RRP is a rare disease characterised by the growth of tumours in the respiratory tract, caused by a…
10 Feb 20
In the Phase 1 clinical trial, OTX-TIC reduced intraocular pressure (IOP) in primary open angle glaucoma or ocular…
Exscientia CEO Andrew Hopkins believes the majority of drug discovery will be done using a combination of AI…
06 Feb 20
The Phase 3 study evaluated RINVOQ for active psoriatic arthritis in adult patients who are intolerant to one…